CLARITIN

LOE Approaching

loratadine

NDAORALTABLET, CHEWABLE
Approved
Aug 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT04645979N/ACompleted

A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico

Started Nov 2020
153 enrolled
Rhinitis, Allergic
NCT03517943Phase 1Completed

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects

Started Apr 2018
29 enrolled
Clinical Pharmacology
NCT03517930Phase 1Completed

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects

Started Apr 2018
52 enrolled
Clinical Pharmacology
NCT03443843Phase 4Completed

A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure

Started Feb 2018
82 enrolled
Rhinitis, Allergic
NCT03196531Phase 1Completed

A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne Tablets

Started Nov 2017
108 enrolled
Healthy